Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026
6 AshfordT
Clinical Use Prostaglandin E1 (PGE1
They are not a recommendation, and no administration protocol is supplied with this product
Compounded Semaglutide GLP-1 is administered through subcutaneous injections, typically starting with a low dose to help minimize potential side effects, such as nausea or gastrointestinal discomfort
Lilly warns that products claiming to be retatrutide outside its trials may contain unknown ingredients, contaminants, too much or too little active material, or a different substance entirely
